### Overview of DPP10-AS3 Gene

**Gene Symbol**: DPP10-AS3

The DPP10-AS3 gene is classified as a long non-coding RNA (lncRNA). It is located on chromosome 2 and is known to play a role in gene regulation, specifically in the context of various physiological and pathological conditions.

### 1. Associated Genes
While no specific genes are universally mentioned in association with DPP10-AS3 in the provided summaries, lncRNAs often interact with multiple genes through regulatory networks. Some genes that have been implicated in overlaps with DPP10-AS3’s functions may include:

- **DPP10**: The protein-coding gene from which DPP10-AS3 is transcribed. DPP10 encodes a protein that modulates the activity of certain membrane-bound dipeptidyl peptidases.
- **DPP4**: This gene encodes an enzyme known to play roles in glucose metabolism and immune response, and may exhibit functional interactions with DPP10.
  
Further investigations into gene expression profiles or co-expression studies in relevant biological conditions might reveal additional gene associations.

### 2. Aging and Age-related Diseases
Current literature emphasizes the role of lncRNAs in aging mechanisms and age-related diseases. While specific details on DPP10-AS3's direct contribution to aging processes or related diseases are limited, some general observations may include:

- **Age-Related Declines**: lncRNAs like DPP10-AS3 can play roles in cellular senescence, apoptosis, and stress responses, which are crucial during aging.
- **Cancer**: Some studies suggest that lncRNAs are implicated in the regulation of pathways associated with cancer progression, which is often exacerbated by aging.
- **Cardiovascular Disease**: Dysregulation of lncRNAs is frequently observed in age-associated cardiovascular pathology, which could implicate DPP10-AS3 indirectly.

### 3. Drug Interactions
While there may not be direct drug interactions specific to DPP10-AS3, its association with DPP10 could implicate the following drug classes:

- **Dipeptidyl Peptidase Inhibitors (DPP4 Inhibitors)**: Drugs such as sitagliptin and saxagliptin are inhibitors that may affect pathways involving DPP10 and indirectly involve DPP10-AS3.
- **Cancer Therapeutics**: Since lncRNAs are potential targets in oncotherapy, any investigational agents targeting pathways modulated by DPP10 or related mechanisms might also influence the regulation of DPP10-AS3.

### 4. Pathways and Biological Processes
DPP10-AS3 is involved in several biological processes and pathways, potentially including:

- **Gene Regulation**: Acting as a regulatory element, influencing the transcription of neighboring genes.
- **Cell Signaling Pathways**: Potential involvement in signaling pathways that affect cell proliferation, differentiation, and apoptosis.
- **Metabolic Pathways**: Due to its proximity to DPP10, it could influence metabolic processes, particularly those relevant to glucose homeostasis and related metabolic syndromes.

### Conclusion
The DPP10-AS3 gene represents an intriguing area of study within the frameworks of gene regulation, aging, and potential therapeutic targets, especially in diseases where both its and associated genes’ functions intersect. For comprehensive understandings, further research is warranted to elucidate detailed mechanisms and specific pathways.